The pharmaceutical company Pfizer has agreed to pay $450 million to Brigham Young University to settle a lawsuit over the drug Celebrex, The Deseret News reported. Brigham Young and one of its professors have accused the company of unfairly using his work conducted at the university for the drug. The announcement of the settlement did not detail terms, but a footnote in a quarterly report issued by Pfizer references a $450 million expense related to the Brigham Young suit.